[1] |
XIAO Yue, LI Tangfei, XUE Qianfu.
Analysis of the efficacy and safety of Peg-IFN-α in the treatment of essential thrombocythemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1049-1055.
|
[2] |
WU Xiongzhi, WANG Xuan, XU Siqi, JU Xia, WANG Shengbin, CHEN Yongquan.
A comparative investigation of the impact of oral midazolam solution and dexmedetomidine nasal spray on preoperative anxiety in pediatric patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 666-670.
|
[3] |
JIA Boying, ZHOU Shuang, WAN Liyan, ZHOU Ying, CUI Yimin.
Drug-induced dysphagia risk in elder people——A pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) database
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1109-1120.
|
[4] |
LIU Min, KONG Xiang, ZHANG Ye, GU Yifei, XIANG Xuemei, HUANG Kai.
Safety analysis on bioequivalence studies of orally inhaled drug products in healthy Chinese subjects#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1131-1138.
|
[5] |
LIANG Meifang, CHEN Qingzhuang, YANG Peiqun, WANG Yong.
Efficacy and safety of generic and branded atorvastatin in patients with ischemic stroke/transient ischemic attack: A real-world study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 785-792.
|
[6] |
DAI Hongyu, YANG Kun, HU Ruchun, ZHOU Hongmei, MA Peimin, HAO Qian.
Duration time and effectiveness of 0.25%ropivacaine for sciatic nerve block in patients with diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1278-1284.
|
[7] |
BAO Jing, CHEN Xiaowen, XIA Liang, ZHAO Yuchen, XIA Ruixiang, XIA Hailong.
Clinical efficacy and safety of ixazomib in the treatment of multiple myeloma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 782-786.
|
[8] |
PAN Luping, SHI Wujie, SHEN Zhipeng.
Efficacy and safety of etoposide combined with carboplatin in children with recurrent medulloblastoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 189-195.
|
[9] |
SHI Lili, LIU Xingan, SHAN Guoyong.
Efficacy and safety of apatinib in the further line treatment for patients with advanced colorectal cancer failed after standard therapy and the preliminary analysis of efficacy predictors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1388-1394.
|
[10] |
YANG Haijing, YU Jicheng, WANG Jingjing, LI Nanyang, WU Jufang, ZHANG Hai, XUE Tao, DAI Weiguo, DING Tianling, CAO Guoying.
Risk management of biological agents in phase I clinical trials: Case sharing
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 44-48.
|
[11] |
WANG Hongzhu, LIN Xianju, ZHU Lijun.
Effect of magnesium sulfate mixed ropivacaine femoral nerve block on lower extremity tourniquet reaction in the patients with knee ligament repair
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 687-692.
|
[12] |
HUA Xudan, XIE Hongyi, YU Shufang.
Analysis of the efficacy, safety and economics of prophylactic antibiotics in high-risk neonates guided by C reaction protein and procalcitonin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 561-566.
|
[13] |
WANG Haili, GONG Tianxiao, ZHOU Shixia, MEI Jiazhuan, ZHANG Zhongmian.
Efficacy and safety of third-line treatment with mesylate apatinib in patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 567-572.
|
[14] |
KANG Hui, YONG Xiaolan, HU Tingting, CHU Bixin, WANG Lantian.
Pharmacokinetic study and safety assessment of lacosamide tablets in Chinese healthy subjects under fasting condition
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 192-197.
|
[15] |
YANG Ke, LI Junling, DU Bin, TIAN Zhongqiu, JING Xiujuan.
Single-arm,one-center, exploratory clinical trial of albumin-bound paclitaxel second and more line therapy for advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1281-1286.
|